CRF Connect Logo
  • Tracks & Learning Series
    VIEW ALL
  • Conferences
  • My Favorites

Innovation

Best Device Concepts and Technological Trends Learning Series

Endovascular Therapies

Advertisement

Innovation >
Endovascular Therapies

Episodes

Primary Outcomes of the Esprit™ BTK Drug-Eluting Resorbable Scaffold for the Treatment of Infrapopliteal Lesions: The LIFE-BTK Randomized Controlled Trial

Primary Outcomes of the Esprit™ BTK Drug-Eluting Resorbable Scaffold for the Treatment of Infrapopliteal Lesions: The LIFE-BTK Randomized Controlled Trial

21 min.

Intelligent Interventions: Personalized Medicine for VTEs (FlowMedical)

Intelligent Interventions: Personalized Medicine for VTEs (FlowMedical)

11 min.

Deep Vein Arterialization for No-Option CLTI Patients: Technology and Clinical Program Update

Deep Vein Arterialization for No-Option CLTI Patients: Technology and Clinical Program Update

10 min.

Angiographic and Clinical Outcomes of the Thin-Strut MAGNITUDE Bioresorbable Scaffold in Patients with Below-the-Knee Arterial Disease: Early Results from the RESOLV I Trial

Angiographic and Clinical Outcomes of the Thin-Strut MAGNITUDE Bioresorbable Scaffold in Patients with Below-the-Knee Arterial Disease: Early Results from the RESOLV I Trial

9 min.

Intentional Coronary Revascularization Versus Conservative Therapy in Patients, who Underwent Successful Peripheral Artery Revascularization due to Critical Limb Ischemia - the INCORPORATE Randomized Clinical Trial

Intentional Coronary Revascularization Versus Conservative Therapy in Patients, who Underwent Successful Peripheral Artery Revascularization due to Critical Limb Ischemia - the INCORPORATE Randomized Clinical Trial

8 min.

Keynote Lecture: Innovation in BTK Intervention: Clinical and Technical Lessons Learned From Recent DCB and DES Trials

Keynote Lecture: Innovation in BTK Intervention: Clinical and Technical Lessons Learned From Recent DCB and DES Trials

10 min.

What Will the Next Trial Designs Look Like for Renal Denervation?

What Will the Next Trial Designs Look Like for Renal Denervation?

22 min.

Renal Denervation — Clinician Perspectives

Renal Denervation — Clinician Perspectives

19 min.

Renal Denervation — Industry Perspectives

Renal Denervation — Industry Perspectives

5 min.

Renal Denervation —  Trialist Perspectives

Renal Denervation — Trialist Perspectives

7 min.

Can Scoring the Calcified Aortic Valve Defer the Need for Permanent Implant (Leaflex): Technology and Clinical Update

Can Scoring the Calcified Aortic Valve Defer the Need for Permanent Implant (Leaflex): Technology and Clinical Update

12 min.

Aspiration Thrombectomy: a Potential Treatment for Pulmonary Embolism in COVID-19

Aspiration Thrombectomy: a Potential Treatment for Pulmonary Embolism in COVID-19

5 min.

Innovation in Interventional PE Therapies

Innovation in Interventional PE Therapies

9 min.

New technology update for CLI : Scaffolds

New technology update for CLI : Scaffolds

8 min.

Reflow Medical’s Temporary Spur DES System

Reflow Medical’s Temporary Spur DES System

3 min.

APTITUDE PLLA BRS (R3 Vascular)

APTITUDE PLLA BRS (R3 Vascular)

4 min.

Hybrid Nano-Coating DES for BTK Disease

Hybrid Nano-Coating DES for BTK Disease

6 min.

Addressing Microvascular Obstruction and No Reflow With a Novel Nanoscale Endovascular Image-Guided Interventional Tool (Pulse NanoMED)

Addressing Microvascular Obstruction and No Reflow With a Novel Nanoscale Endovascular Image-Guided Interventional Tool (Pulse NanoMED)

4 min.

Endovascular Sequestration of High-Risk Carotid Lesions Using the MicroNET-Covered Embolic Prevention Stent in Consecutive Patients With Symptoms or Signs of Carotid Stenosis-Related Cerebral Injury: An Investigator-Initiated, Intravascular, Ultrasound-Controlled, Multinational, Multispecialty Trial (CGuard OPTIMA)

Endovascular Sequestration of High-Risk Carotid Lesions Using the MicroNET-Covered Embolic Prevention Stent in Consecutive Patients With Symptoms or Signs of Carotid Stenosis-Related Cerebral Injury: An Investigator-Initiated, Intravascular, Ultrasound-Controlled, Multinational, Multispecialty Trial (CGuard OPTIMA)

5 min.

Novel Devices to Treat Hypertension: What Else Should We Expect in the Near Future?

Novel Devices to Treat Hypertension: What Else Should We Expect in the Near Future?

4 min.

Update on the RADIANCE Clinical Trials Program (Ultra-Sound Renal Denervation)

Update on the RADIANCE Clinical Trials Program (Ultra-Sound Renal Denervation)

10 min.

This website uses cookies to ensure you get the best experience on our website. Read More